Clinical evolution

How in silico trials are making personalized medicine a reality

How in silico trials are making personalized medicine a reality

By Melissa Fassbender

The biopharma industry is on the precipice of making personalized medicine a reality with access to massive amounts of data, computing power, and artificial intelligence to run in silico clinical trials, says GNS Healthcare CEO.

(Image: Getty/metamorworks)

At the source

The top 3 myths of ‘going digital’ (and the realities)

By Melissa Fassbender

The top three myths of ‘going digital’ relate to the industry’s self-image, the perceived role of technology, and current market conditions – still, digital is not a fad and is here to stay, says industry expert.